Megan L. Matthews
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Dr. Megan L. Matthews is an Assistant Professor at the University of Pennsylvania, USA. Her research focuses on activity-based protein profiling, targeted degradation medicines, and the discovery of inhibitors against protein-derived electrophilic cofactors. She has published recent articles exploring the proteolysis of RHBDL4 and chemoproteomic ligand discovery.
Articles (4)
Hydralazine (HYZ), a treatment for preeclampsia and hypertensive crisis, is listed by the World Health Organization as an essential medicine. Its mode of action has remained unknown through its seven decades of clinical use. Here, we identify 2-aminoethanethiol dioxygenase (ADO), a key mediator of targeted protein degradation, as a selective HYZ target. The drug chelates ADO’s metallocofactor and can alkylate one of its ligands. The resultant inactivation stabilizes regulators of G protein signaling (RGS4 and RGS5) that ADO normally marks for proteolysis, explaining the drug’s vasodilatory activity and comporting with observations of diminished RGS levels in both clinical preeclampsia and a mouse model thereof. Its inhibition of ADO suggested use of HYZ against glioblastoma (GBM); indeed, a single dose robustly senesces cultured GBM cells. By establishing ADO as a nexus for GBM and preeclampsia and connecting it to HYZ, the results create opportunities for directed tailoring of the old drug for new therapies.
Year:
2025
Year:
2024
Year:
2024
Year:
2022
Collaborators (5)
Jiasong (Jason) Li
Assistant Professor of Research
University of Texas at San Antonio
William Parsons
Associate Professor
Oberlin College
Zongtao Lin
Assistant Professor
Rutgers University
J. Martin Bollinger
Marker Professor of Natural Products Chemistry
Pennsylvania State University
Kirill A. Martemyanov
Professor and Chair
University of Miami
Make your next move.
Prepare your application
Review drafts before you send them.